Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Galapagos NV (GLPG)

Amsterdam
Currency in EUR
Disclaimer
29.62
-0.72(-2.37%)
Real-time Data

GLPG Comments

75 eoy
$45 soon
Here we are…
UPDATE 2!! DO NOT BUY THIS YET!!! I Just found out where the bottom for this stock is = 43 to 47 EURO for this year! If the bottom is reached next year it will be a bit higher. Trust me.
Mr Buffett, you're clueless.
Fine. Good luck with your crystal ball.
You were soo right!!! And what will happen now? Is it bottommed finally and where is the top technically speaking.
Update: it looks like it broke out of the falling wedge. The odds of this going higher are better now
Lol u turd minded. Keep talking bull and then bear anf then bull thesis🤣
nice job on profit! now a beautiful takeover. I'm guessing Pharming Group
no earnings today? or they failed even on that???
45$ is a good entry point
This trash is going to 32 Euro. Have fun!
ooh, u bougt in too high?
 no
Ready for takeover?!
It makes for a good takeover now!
Verkopen die boel - teveel vraagtekens. Wat ben je met hoop cash als je bedrijf een holle doos is...
Geen enkel medicijn meer op de plank wat verkoopbaar is.
wel 5 miljard cash waarmee ze overnames kunnen doen 😏
guys, any good news that could wake up this one? I had it on red when it went downs 18.5% in a day.... is long way ...
RIP
Enig nieuws omtrent de voordracht en reacties op conference bij JP morgan?
zelfde koers als vorig jaar , 1 groot verschil is dat ze nu wel omzet draaien. ik zie dit aandeel niet verder zakken.
Ze kunnen dus nog dieper zakken -18.72% weer
66.10 nu
58 nu
Zijn alle vertrouwen kwijt in galapagos. Zal een lange weg zijn voor men er terug vertrouwen in krijgt. Als de ceo ook aandelen verkoopt voor het aandeel 20% zakt en dan terug koopt
waardeloos management. Niks communiceren omtrent Halloweenmeeting. Dan zelf cashen ondanks het feit dat aandelen 40% van ATH stond. En nu instappen. Hoop echt dat de VEB hier vol achter aan gaan. Onno en zijn oplichtersbende
@ Tony: dat heb ik eigenhandig meer CEO's zien doen hoor; Je zou nog verschieten wie
bought at 122, long term goal (+-1y) 150
You should sell it when you can and invest in the American stock market. There is too much regulation here that keeps the market down. Stocks like these go up big on speculation, but decline a lot on failed medicine.
Check out Nio, Palantir technologies for huge profits or Tesla for a safer bet. The future is in full self drive. Also check out what Cathy Wood says. Everything she invests in turns to gold.
Long term goal
What a POS!! It drops suddenly
you must be new to this?
Man this should recover back to 120-130 at least. It is still a reputable bio company
so what was the reason of that deep..?Earnings looks like expected.. did company failed on some research ?
one of their products did not get cleared by FDA
what a scam this stock, never believes CEOs is the lesson
Would buy the dip apply here? :D
My God :o
what a deep fall!
Ouch
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.